Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Global Metabolic Disorders Treatment Market Insights, Forecast to 2029

Global Metabolic Disorders Treatment Market Insights, Forecast to 2029

Industry: Medical Care

Published: 2023-08-28

Pages: 105 Pages

Report ld: 1623432

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Market Analysis and Insights: Global Metabolic Disorders Treatment Market

Global Metabolic Disorders Treatment market is expected to reach to US$ 90370 million in 2023, with a positive growth of %, compared with US$ 82150 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Metabolic Disorders Treatment industry is evaluated to reach US$ 160970 million in 2029. The CAGR will be 10.1% during 2023 to 2029.

The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure.

Report Covers:
This report presents an overview of global Metabolic Disorders Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Metabolic Disorders Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report:

Report Metric
Details
Report Title
Global Metabolic Disorders Treatment Market Insights, Forecast to 2029
Market Size Available for Years
2023-2029
Global Metabolic Disorders Treatment Companies Covered
Merck
Novartis
Takeda Pharmaceutical
Astra Zeneca
Boehringer Ingelheim
KOWA
Kythera
Fuji yakuhin
LG Life Science
Metsubishi Tanabe Pharma
Global Metabolic Disorders Treatment Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue analysis from 2018 to 2029
Chapter 3: Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Product revenue analysis by type from 2018 to 2029 globally
Chapter 5: Product revenue analysis by application from 2018 to 2029 globally
Chapter 6: Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9: Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Companies’ outline, covering company’s basic information, major business, Metabolic Disorders Treatment introduction, etc. Metabolic Disorders Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12: QYResearch’s Conclusions of Metabolic Disorders Treatment
Chapter 13: Methodology and Data Sources adopted by QYResearch

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
        1.2.2 Glycogen Metabolism Disease Drug
        1.2.3 Lipid Metabolism Disease Drug
        1.2.4 Amino Acid Metabolism Drug
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Retail Pharmacy
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Metabolic Disorders Treatment Market Perspective (2018-2029)
    2.2 Global Metabolic Disorders Treatment Growth Trends by Region
        2.2.1 Metabolic Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Metabolic Disorders Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Metabolic Disorders Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Metabolic Disorders Treatment Market Dynamics
        2.3.1 Metabolic Disorders Treatment Industry Trends
        2.3.2 Metabolic Disorders Treatment Market Drivers
        2.3.3 Metabolic Disorders Treatment Market Challenges
        2.3.4 Metabolic Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Metabolic Disorders Treatment by Players
        3.1.1 Global Metabolic Disorders Treatment Revenue by Players (2018-2023)
        3.1.2 Global Metabolic Disorders Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Metabolic Disorders Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
    3.4 Global Metabolic Disorders Treatment Market Concentration Ratio
        3.4.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2022
    3.5 Global Key Players of Metabolic Disorders Treatment Head office and Area Served
    3.6 Global Key Players of Metabolic Disorders Treatment, Product and Application
    3.7 Global Key Players of Metabolic Disorders Treatment, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Metabolic Disorders Treatment Breakdown Data by Type
    4.1 Global Metabolic Disorders Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Metabolic Disorders Treatment Forecasted Market Size by Type (2024-2029)

5 Metabolic Disorders Treatment Breakdown Data by Application
    5.1 Global Metabolic Disorders Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029)

6 North America
    6.1 North America Metabolic Disorders Treatment Market Size (2018-2029)
    6.2 North America Metabolic Disorders Treatment Market Size by Type
        6.2.1 North America Metabolic Disorders Treatment Market Size by Type (2018-2023)
        6.2.2 North America Metabolic Disorders Treatment Market Size by Type (2024-2029)
        6.2.3 North America Metabolic Disorders Treatment Market Share by Type (2018-2029)
    6.3 North America Metabolic Disorders Treatment Market Size by Application
        6.3.1 North America Metabolic Disorders Treatment Market Size by Application (2018-2023)
        6.3.2 North America Metabolic Disorders Treatment Market Size by Application (2024-2029)
        6.3.3 North America Metabolic Disorders Treatment Market Share by Application (2018-2029)
    6.4 North America Metabolic Disorders Treatment Market Size by Country
        6.4.1 North America Metabolic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
        6.4.2 North America Metabolic Disorders Treatment Market Size by Country (2018-2023)
        6.4.3 North America Metabolic Disorders Treatment Market Size by Country (2024-2029)
        6.4.4 the United States
        6.4.5 Canada

7 Europe
    7.1 Europe Metabolic Disorders Treatment Market Size (2018-2029)
    7.2 Europe Metabolic Disorders Treatment Market Size by Type
        7.2.1 Europe Metabolic Disorders Treatment Market Size by Type (2018-2023)
        7.2.2 Europe Metabolic Disorders Treatment Market Size by Type (2024-2029)
        7.2.3 Europe Metabolic Disorders Treatment Market Share by Type (2018-2029)
    7.3 Europe Metabolic Disorders Treatment Market Size by Application
        7.3.1 Europe Metabolic Disorders Treatment Market Size by Application (2018-2023)
        7.3.2 Europe Metabolic Disorders Treatment Market Size by Application (2024-2029)
        7.3.3 Europe Metabolic Disorders Treatment Market Share by Application (2018-2029)
    7.4 Europe Metabolic Disorders Treatment Market Size by Country
        7.4.1 Europe Metabolic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
        7.4.2 Europe Metabolic Disorders Treatment Market Size by Country (2018-2023)
        7.4.3 Europe Metabolic Disorders Treatment Market Size by Country (2024-2029)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Metabolic Disorders Treatment Market Size (2018-2029)
    8.2 China Metabolic Disorders Treatment Market Size by Type
        8.2.1 China Metabolic Disorders Treatment Market Size by Type (2018-2023)
        8.2.2 China Metabolic Disorders Treatment Market Size by Type (2024-2029)
        8.2.3 China Metabolic Disorders Treatment Market Share by Type (2018-2029)
    8.3 China Metabolic Disorders Treatment Market Size by Application
        8.3.1 China Metabolic Disorders Treatment Market Size by Application (2018-2023)
        8.3.2 China Metabolic Disorders Treatment Market Size by Application (2024-2029)
        8.3.3 China Metabolic Disorders Treatment Market Share by Application (2018-2029)

9 Asia (excluding China)
    9.1 Asia Metabolic Disorders Treatment Market Size (2018-2029)
    9.2 Asia Metabolic Disorders Treatment Market Size by Type
        9.2.1 Asia Metabolic Disorders Treatment Market Size by Type (2018-2023)
        9.2.2 Asia Metabolic Disorders Treatment Market Size by Type (2024-2029)
        9.2.3 Asia Metabolic Disorders Treatment Market Share by Type (2018-2029)
    9.3 Asia Metabolic Disorders Treatment Market Size by Application
        9.3.1 Asia Metabolic Disorders Treatment Market Size by Application (2018-2023)
        9.3.2 Asia Metabolic Disorders Treatment Market Size by Application (2024-2029)
        9.3.3 Asia Metabolic Disorders Treatment Market Share by Application (2018-2029)
    9.4 Asia Metabolic Disorders Treatment Market Size by Region
        9.4.1 Asia Metabolic Disorders Treatment Market Size by Region: 2018 VS 2022 VS 2029
        9.4.2 Asia Metabolic Disorders Treatment Market Size by Region (2018-2023)
        9.4.3 Asia Metabolic Disorders Treatment Market Size by Region (2024-2029)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size (2018-2029)
    10.2 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Type (2018-2023)
        10.2.2 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Type (2024-2029)
        10.2.3 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Share by Type (2018-2029)
    10.3 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Application (2018-2023)
        10.3.2 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Application (2024-2029)
        10.3.3 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Share by Application (2018-2029)
    10.4 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country: 2018 VS 2022 VS 2029
        10.4.2 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country (2018-2023)
        10.4.3 Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country (2024-2029)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Details
        11.1.2 Merck Business Overview
        11.1.3 Merck Metabolic Disorders Treatment Introduction
        11.1.4 Merck Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.1.5 Merck Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Metabolic Disorders Treatment Introduction
        11.2.4 Novartis Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.2.5 Novartis Recent Developments
    11.3 Takeda Pharmaceutical
        11.3.1 Takeda Pharmaceutical Company Details
        11.3.2 Takeda Pharmaceutical Business Overview
        11.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Introduction
        11.3.4 Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.3.5 Takeda Pharmaceutical Recent Developments
    11.4 Astra Zeneca
        11.4.1 Astra Zeneca Company Details
        11.4.2 Astra Zeneca Business Overview
        11.4.3 Astra Zeneca Metabolic Disorders Treatment Introduction
        11.4.4 Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.4.5 Astra Zeneca Recent Developments
    11.5 Boehringer Ingelheim
        11.5.1 Boehringer Ingelheim Company Details
        11.5.2 Boehringer Ingelheim Business Overview
        11.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Introduction
        11.5.4 Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.5.5 Boehringer Ingelheim Recent Developments
    11.6 KOWA
        11.6.1 KOWA Company Details
        11.6.2 KOWA Business Overview
        11.6.3 KOWA Metabolic Disorders Treatment Introduction
        11.6.4 KOWA Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.6.5 KOWA Recent Developments
    11.7 Kythera
        11.7.1 Kythera Company Details
        11.7.2 Kythera Business Overview
        11.7.3 Kythera Metabolic Disorders Treatment Introduction
        11.7.4 Kythera Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.7.5 Kythera Recent Developments
    11.8 Fuji yakuhin
        11.8.1 Fuji yakuhin Company Details
        11.8.2 Fuji yakuhin Business Overview
        11.8.3 Fuji yakuhin Metabolic Disorders Treatment Introduction
        11.8.4 Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.8.5 Fuji yakuhin Recent Developments
    11.9 LG Life Science
        11.9.1 LG Life Science Company Details
        11.9.2 LG Life Science Business Overview
        11.9.3 LG Life Science Metabolic Disorders Treatment Introduction
        11.9.4 LG Life Science Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.9.5 LG Life Science Recent Developments
    11.10 Metsubishi Tanabe Pharma
        11.10.1 Metsubishi Tanabe Pharma Company Details
        11.10.2 Metsubishi Tanabe Pharma Business Overview
        11.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Introduction
        11.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2018-2023)
        11.10.5 Metsubishi Tanabe Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Metabolic Disorders Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Glycogen Metabolism Disease Drug
    Table 3. Key Players of Lipid Metabolism Disease Drug
    Table 4. Key Players of Amino Acid Metabolism Drug
    Table 5. Key Players of Other
    Table 6. Global Metabolic Disorders Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 7. Global Metabolic Disorders Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Metabolic Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Metabolic Disorders Treatment Market Share by Region (2018-2023)
    Table 10. Global Metabolic Disorders Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Metabolic Disorders Treatment Market Share by Region (2024-2029)
    Table 12. Metabolic Disorders Treatment Market Trends
    Table 13. Metabolic Disorders Treatment Market Drivers
    Table 14. Metabolic Disorders Treatment Market Challenges
    Table 15. Metabolic Disorders Treatment Market Restraints
    Table 16. Global Metabolic Disorders Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Metabolic Disorders Treatment Revenue Share by Players (2018-2023)
    Table 18. Global Top Metabolic Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Table 19. Global Metabolic Disorders Treatment Industry Ranking 2021 VS 2022 VS 2023
    Table 20. Global 5 Largest Players Market Share by Metabolic Disorders Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Global Key Players of Metabolic Disorders Treatment, Headquarters and Area Served
    Table 22. Global Key Players of Metabolic Disorders Treatment, Product and Application
    Table 23. Global Key Players of Metabolic Disorders Treatment, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Metabolic Disorders Treatment Revenue Market Share by Type (2018-2023)
    Table 27. Global Metabolic Disorders Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Metabolic Disorders Treatment Revenue Market Share by Type (2024-2029)
    Table 29. Global Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Metabolic Disorders Treatment Revenue Share by Application (2018-2023)
    Table 31. Global Metabolic Disorders Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Metabolic Disorders Treatment Revenue Share by Application (2024-2029)
    Table 33. North America Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 34. North America Metabolic Disorders Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 35. North America Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 36. North America Metabolic Disorders Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 37. North America Metabolic Disorders Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. North America Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 39. North America Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Europe Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 41. Europe Metabolic Disorders Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 42. Europe Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 43. Europe Metabolic Disorders Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 44. Europe Metabolic Disorders Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Europe Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Europe Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 47. China Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 48. China Metabolic Disorders Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 49. China Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 50. China Metabolic Disorders Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 51. Asia Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 52. Asia Metabolic Disorders Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 53. Asia Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 54. Asia Metabolic Disorders Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 55. Asia Metabolic Disorders Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 56. Asia Metabolic Disorders Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 57. Asia Metabolic Disorders Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Type (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Application (2024-2029) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Metabolic Disorders Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 63. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 65. Merck Company Details
    Table 66. Merck Business Overview
    Table 67. Merck Metabolic Disorders Treatment Product
    Table 68. Merck Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 69. Merck Recent Developments
    Table 70. Novartis Company Details
    Table 71. Novartis Business Overview
    Table 72. Novartis Metabolic Disorders Treatment Product
    Table 73. Novartis Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 74. Novartis Recent Developments
    Table 75. Takeda Pharmaceutical Company Details
    Table 76. Takeda Pharmaceutical Business Overview
    Table 77. Takeda Pharmaceutical Metabolic Disorders Treatment Product
    Table 78. Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 79. Takeda Pharmaceutical Recent Developments
    Table 80. Astra Zeneca Company Details
    Table 81. Astra Zeneca Business Overview
    Table 82. Astra Zeneca Metabolic Disorders Treatment Product
    Table 83. Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 84. Astra Zeneca Recent Developments
    Table 85. Boehringer Ingelheim Company Details
    Table 86. Boehringer Ingelheim Business Overview
    Table 87. Boehringer Ingelheim Metabolic Disorders Treatment Product
    Table 88. Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 89. Boehringer Ingelheim Recent Developments
    Table 90. KOWA Company Details
    Table 91. KOWA Business Overview
    Table 92. KOWA Metabolic Disorders Treatment Product
    Table 93. KOWA Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 94. KOWA Recent Developments
    Table 95. Kythera Company Details
    Table 96. Kythera Business Overview
    Table 97. Kythera Metabolic Disorders Treatment Product
    Table 98. Kythera Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 99. Kythera Recent Developments
    Table 100. Fuji yakuhin Company Details
    Table 101. Fuji yakuhin Business Overview
    Table 102. Fuji yakuhin Metabolic Disorders Treatment Product
    Table 103. Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 104. Fuji yakuhin Recent Developments
    Table 105. LG Life Science Company Details
    Table 106. LG Life Science Business Overview
    Table 107. LG Life Science Metabolic Disorders Treatment Product
    Table 108. LG Life Science Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 109. LG Life Science Recent Developments
    Table 110. Metsubishi Tanabe Pharma Company Details
    Table 111. Metsubishi Tanabe Pharma Business Overview
    Table 112. Metsubishi Tanabe Pharma Metabolic Disorders Treatment Product
    Table 113. Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2018-2023) & (US$ Million)
    Table 114. Metsubishi Tanabe Pharma Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Metabolic Disorders Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Metabolic Disorders Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Glycogen Metabolism Disease Drug Features
    Figure 4. Lipid Metabolism Disease Drug Features
    Figure 5. Amino Acid Metabolism Drug Features
    Figure 6. Other Features
    Figure 7. Global Metabolic Disorders Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Metabolic Disorders Treatment Market Share by Application: 2022 VS 2029
    Figure 9. Hospital Case Studies
    Figure 10. Retail Pharmacy Case Studies
    Figure 11. Metabolic Disorders Treatment Report Years Considered
    Figure 12. Global Metabolic Disorders Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 13. Global Metabolic Disorders Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 14. Global Metabolic Disorders Treatment Market Share by Region: 2022 VS 2029
    Figure 15. Global Metabolic Disorders Treatment Market Share by Players in 2022
    Figure 16. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolic Disorders Treatment as of 2022)
    Figure 17. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2022
    Figure 18. North America Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. North America Metabolic Disorders Treatment Market Share by Type (2018-2029)
    Figure 20. North America Metabolic Disorders Treatment Market Share by Application (2018-2029)
    Figure 21. North America Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 22. United States Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Metabolic Disorders Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 25. Europe Metabolic Disorders Treatment Market Share by Type (2018-2029)
    Figure 26. Europe Metabolic Disorders Treatment Market Share by Application (2018-2029)
    Figure 27. Europe Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 28. Germany Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. France Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. U.K. Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Italy Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Russia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Nordic Countries Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. China Metabolic Disorders Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 35. China Metabolic Disorders Treatment Market Share by Type (2018-2029)
    Figure 36. China Metabolic Disorders Treatment Market Share by Application (2018-2029)
    Figure 37. Asia Metabolic Disorders Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 38. Asia Metabolic Disorders Treatment Market Share by Type (2018-2029)
    Figure 39. Asia Metabolic Disorders Treatment Market Share by Application (2018-2029)
    Figure 40. Asia Metabolic Disorders Treatment Market Share by Region (2018-2029)
    Figure 41. Japan Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. South Korea Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. China Taiwan Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. India Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Australia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Size YoY (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Share by Type (2018-2029)
    Figure 49. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Share by Application (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Metabolic Disorders Treatment Market Share by Country (2018-2029)
    Figure 51. Brazil Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 52. Mexico Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Turkey Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Israel Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. GCC Countries Metabolic Disorders Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 58. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 60. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 62. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 63. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 64. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 65. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 66. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2018-2023)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed

Description

Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers Glycogen Metabolism Disease, Lipid Metabolism Disease, Amino Acid Metabolism, Metal Metabolism Disease, etc.

Market Analysis and Insights: Global Metabolic Disorders Treatment Market

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue analysis from 2018 to 2029
Chapter 3: Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Product revenue analysis by type from 2018 to 2029 globally
Chapter 5: Product revenue analysis by application from 2018 to 2029 globally
Chapter 6: Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9: Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Companies’ outline, covering company’s basic information, major business, Metabolic Disorders Treatment introduction, etc. Metabolic Disorders Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12: QYResearch’s Conclusions of Metabolic Disorders Treatment
Chapter 13: Methodology and Data Sources adopted by QYResearch

Related Reports

Global Metabolic Disorders Treatment Market Research Report 2023
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-07-25
Pages: 86
USD 2900.00
(Single User License)
Global Metabolic Disorders Treatment Industry Research Report, Growth Trends and Competitive Analysis 2023-2029
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-05-30
Pages: 107
USD 5600.00
(Single User License)
Global Metabolic Disorders Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-07-25
Pages: 104
USD 3350.00
(Single User License)
Metabolic Disorders Treatment - Global Market Insights and Sales Trends 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2023-11-15
Pages: 102
USD 3350.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2024
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-05
Pages: 87
USD 2900.00
(Single User License)
Metabolic Disorders Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-01-24
Pages: 115
USD 3950.00
(Single User License)
Global Metabolic Disorders Treatment Market Insights, Forecast to 2030
Metabolism Drugs is used to treat the metabolic disease in humans. Metabolic disease mainly covers G
Published: 2024-04-25
Pages: 105
USD 4900.00
(Single User License)
Global Metabolic Disorders Treatment Market Research Report 2025
The global market for Metabolic Disorders Treatment was valued at US$ 98580 million in the year 2024
Published: 2025-02-27
Pages: 76
USD 2900.00
(Single User License)
Metabolic Disorders Treatment- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Metabolic Disorders Treatment was estimated to be worth US$ 98580 million in 2
Published: 2025-02-27
Pages: 98
USD 3950.00
(Single User License)